Latest

anosmia

·March 12, 2024·8 min read

Smell Loss Heightens Safety Risks

A new study highlights the significant safety concerns and hazards faced by individuals with olfactory dysfunction, including a higher incidence of gas safety scares. The survey of 432 participants, conducted from February to September 2022, found that a large majority are concerned about their safety, particularly regarding gas leaks, smoke detection, and spoiled food, with over a third experiencing related hazardous events in the past five years.

Featured Neuroscience Psychology

·June 26, 2023·6 min read

A Fading Sense of Smell: New Predictor of Late-Life Depression?

Researchers identified a correlation between loss of smell and an increased risk of developing late-life depression. The study, spanning eight years and involving more than 2,000 older adults, doesn't establish causality but suggests that an impaired sense of smell might indicate overall health and well-being.

Featured Neurology Neuroscience

·April 17, 2023·4 min read

Long COVID Smell Loss Linked to Changes in the Brain

Anosmia, or the loss of the sense of smell caused by long COVID is linked to changes in the brain that prevents correct olfactory processing.

Featured Neurology Neuroscience

·August 2, 2022·4 min read

Could Loss of Smell From COVID-19 Create Future ‘Dementia Wave?’

Study questions whether smell loss associated with COVID-19 infection may increase the risk of developing dementia later in life.

This diagram shows how inflammation occurs in the nasal passage

Featured Neurology Neuroscience

·April 11, 2022·6 min read

Inflammation Caused by COVID-19, Rather Than the Virus Itself, May Lead To Loss of Smell

Anosmia, the loss of the sense of smell which is a common symptom of COVID-19, may be a secondary consequence of immune system inflammation rather than a direct action of the virus.

This shows a woman in a facemask holding a flower

Featured Neurology Neuroscience

·April 10, 2022·6 min read

A Way to Prevent Loss of Smell and Taste From COVID-19

Camostat mesylate, an oral medication commonly prescribed to treat pancreatitis, reduces both the loss of smell and taste in those with COVID-19 infection.

Featured Neurology Neuroscience

·August 3, 2021·2 min read

Thinking Impaired in 60% of COVID-19 Survivors

60% of 400 coronavirus survivors experienced lasting cognitive impairment, a new study reports. Cognitive problems were found in those who experienced mild-to-moderate COVID symptoms, as well as those who experienced more severe symptoms. One in three of the survivors experienced severe cognitive symptoms, akin to dementia.

This is a drawing of a man in a facemask

Featured Genetics Neuroscience

·July 24, 2020·7 min read

How COVID-19 Causes Smell Loss

Infection of non-neuronal supporting cells in the nose and forebrain may be responsible for the olfactory problems associated with COVID-19. Findings suggest olfactory sensory neurons are not vulnerable to coronavirus infection as they do not express ACE2.

This shows a woman in a facemask smelling a flower

Featured Neuroscience

·April 27, 2020·5 min read

Loss of smell associated with milder clinical course and less hospitalizations in COVID-19

COVID-19 patients who reported smell loss as a symptom of their infection are ten times less likely to be hospitalized for coronavirus than those who do not report anosmia.

Featured Neuroscience

·March 23, 2020·1 min read

Loss of smell sense first sign of COVID-19

As many as one in three COVID-19 patients report smell loss as an early symptom of the infection. Researchers say the loss of smell could be used as a key clinical indicator of infection in otherwise symptom-free or pre-symptomatic carriers of coronavirus.